Vanda Pharmaceuticals Inc. (VNDA) earnings
VNDA earnings moved a median of -2.41% by the close. Quarterly and annual VNDA reports and results, each read against the price at its own news timestamp. Back to the VNDA overview →
30 measured VNDA earnings events.
Where these VNDA earnings landedvs 30 measured VNDA earnings reactions
| Middle 50% of VNDA earnings reactions | -4.74% to +2.38% |
|---|---|
| Median reaction (to close) | -2.41% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 VNDA earnings events with a measured close landed between -4.74% and +2.38%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Vanda Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -1.09% | +11.20% | |
| Vanda Pharmaceuticals Reports Second Quarter 2026 Financial Results | Press release | -1.09% | +11.20% | |
| Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026 | Press release | +0.59% | +1.97% | |
| Form 10-Q Vanda Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -1.29% | -8.32% | |
| Vanda Pharmaceuticals Reports First Quarter 2026 Financial Results | Press release | -1.29% | -8.32% | |
| Vanda Pharmaceuticals to Announce First Quarter 2026 Financial Results on May 6, 2026 | Press release | -0.71% | +0.71% | |
| Form 10-K Vanda Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -4.20% | -14.41% | |
| Form 10-Q Vanda Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -4.22% | -13.25% | |
| Vanda Pharmaceuticals Reports Third Quarter 2025 Financial Results | Press release | -4.22% | -13.25% | |
| Vanda Pharmaceuticals to Announce Third Quarter 2025 Financial Results on October 29, 2025 | Press release | -0.56% | +2.62% | |
| Form 10-Q Vanda Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | -3.27% | -3.84% | |
| Vanda Pharmaceuticals Reports Second Quarter 2025 Financial Results | Press release | -3.27% | -3.84% | |
| Vanda Pharmaceuticals to Announce Second Quarter 2025 Financial Results on July 31, 2025 | Press release | +1.44% | -1.24% | |
| Form 10-Q Vanda Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | -2.03% | -4.74% | |
| Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results | Press release | -2.03% | -4.74% | |
| Vanda Pharmaceuticals to Announce First Quarter 2025 Financial Results on May 7, 2025 | Press release | +1.13% | +3.16% | |
| Form 10-K Vanda Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | -1.32% | -1.76% | |
| Form 10-Q Vanda Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | +3.75% | +4.58% | |
| Vanda Pharmaceuticals Reports Third Quarter 2024 Financial Results | Press release | +3.75% | +4.58% | |
| Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024 | Press release | -2.10% | -2.10% | |
| Form 10-Q Vanda Pharmaceuticals For: Jun 30 | SEC filing · Form 10-Q | +0.37% | -3.75% | |
| Vanda Pharmaceuticals Reports Second Quarter 2024 Financial Results | Press release | +0.37% | -3.75% | |
| Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024 | Press release | +0.00% | -0.64% | |
| Form 10-Q Vanda Pharmaceuticals For: Mar 31 | SEC filing · Form 10-Q | +4.47% | -2.72% | |
| Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results | Press release | +4.47% | -2.72% | |
| Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024 | Press release | +1.47% | +0.21% | |
| Form 10-K Vanda Pharmaceuticals For: Dec 31 | SEC filing · Form 10-K | +6.39% | +11.51% | |
| Form 10-Q Vanda Pharmaceuticals For: Sep 30 | SEC filing · Form 10-Q | -7.42% | -19.14% | |
| Vanda Pharmaceuticals Reports Third Quarter 2023 Financial Results | Press release | -7.42% | -19.14% | |
| Vanda Pharmaceuticals to Announce Third Quarter 2023 Financial Results on November 8, 2023 | Press release | +1.61% | +2.52% |
Keep exploring
More VNDA: analyst actions → · SEC filings → · VNDA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Bio-Techne Corp (TECH) | 363 | -0.06% | 44% |
| Tenet Healthcare Corporation (THC) | 363 | +0.22% | 60% |
| Rezolute, Inc. - (NV) (RZLT) | 362 | -0.23% | 44% |
| Erytech Pharma S.A. - American Depositary Shares (ERYP) | 360 | 0.00% | 29% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.